Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not yet recruiting Not applicable Interventional

ExosomeDx in MRI-negative Men With High PSA

ClinicalTrials.gov ID: NCT06966089

Public ClinicalTrials.gov record NCT06966089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 11:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of Urinary Exosomes as a Risk Stratification Tool Among Men With Elevated PSAs and Negative Prostate MRIs

Study identification

NCT ID
NCT06966089
Recruitment status
Not yet recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Icahn School of Medicine at Mount Sinai
Other
Enrollment
425 participants

Conditions and interventions

Interventions

  • Urinary ExoDx test Device
  • Transrectal ultrasound-guided prostate biopsy Diagnostic Test
  • Transperineal 12-core prostate biopsy Diagnostic Test

Device · Diagnostic Test

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2025
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update posted
May 10, 2025

2025 – 2026

United States locations

U.S. sites
6
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Mount Sinai Beth Israel / Union Square New York New York 10003
Mount Sinai West New York New York 10019
Mount Sinai Morningside New York New York 10025
Mount Sinai Hospital New York New York 10029
Mount Sinai Queens New York New York 11102
Mount Sinai Brooklyn New York New York 11234

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06966089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06966089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →